Evidence map›Paper›PMID 27087823›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

Cardioprotective Effects of Genistin in Rat Myocardial Ischemia-Reperfusion Injury Studies by Regulation of P2X7/NF-κB Pathway.

Meng Gu, Ai-Bin Zheng, Jing Jin, Yue Cui, Ning Zhang, Zhi-Ping Che, Yan Wang, Jie Zhan, Wen-Juan Tu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Assessment of the biosafety profile ofWorld journal of cardiology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Plants (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Frontiers in pharmacology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Meng GuDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Ai-Bin ZhengDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Jing JinDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Yue CuiDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Ning ZhangDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Zhi-Ping CheDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Yan WangDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Jie ZhanDepartment of Clinical Laboratory, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Wen-Juan TuDepartment of Neonatal, Changzhou Children's Hospital, Changzhou, Jiangsu 213001, China.
Hangzhou Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to assess the effects and mechanisms of genistin in the rat model of myocardial ischemia reperfusion injury. The rat hearts were exposed to the left anterior descending coronary artery (LAD) ligation for 30 min followed by 1 h of reperfusion. In the rat of myocardial ischemia/reperfusion (MI/R), it was found that genistin pretreatment reduced myocardial infarct size, improved the heart rate, and decreased creatine kinase (CK) and lactate dehydrogenase (LDH) levels in coronary flow. This pretreatment also increased catalase (CAT), superoxide dismutase (SOD) activities but decreased glutathione (GSH), malondialdehyde (MDA) levels. Furthermore, we determined that genistin can ameliorate the impaired mitochondrial morphology and oxidation system; interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) levels were also recovered. Besides, related-proteins of nuclear factor kappa-B (NF-κB) signal pathway activated by P2X7 were investigated to determine the molecular mechanism of genistin and their expressions were measured by western blot. These results presented here demonstrated that genistin enhanced the protective effect on the rats with myocardial ischemia reperfusion injury. Therefore, the cardioprotective effects of genistin may rely on its antioxidant and anti-inflammatory activities via suppression of P2X7/NF-κB pathways.

Identifiers

PMID27087823
PMCPMC4818796
OpenAlexW2298556838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.